116 related articles for article (PubMed ID: 1635064)
1. Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.
Lin HS; Rampersaud AA; Zimmerman K; Steinberg MI; Boyd DB
J Med Chem; 1992 Jul; 35(14):2658-67. PubMed ID: 1635064
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
[TBL] [Abstract][Full Text] [Related]
3. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
[TBL] [Abstract][Full Text] [Related]
5. The conformation and activity relationship of fused analogs of DuP753.
Yoo SE; Shin YA; Lee SH; Kim NJ
Bioorg Med Chem; 1995 Mar; 3(3):289-95. PubMed ID: 7606390
[TBL] [Abstract][Full Text] [Related]
6. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
7. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
[TBL] [Abstract][Full Text] [Related]
8. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
Smith JR; Wahhab A; Moore D; Ganter RC; Moore GJ
Drug Des Discov; 1994 Nov; 12(2):113-9. PubMed ID: 9116166
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.
Bühlmayer P; Criscione L; Fuhrer W; Furet P; de Gasparo M; Stutz S; Whitebread S
J Med Chem; 1991 Oct; 34(10):3105-14. PubMed ID: 1920360
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units.
Angiolini M; Belvisi L; Poma D; Salimbeni A; Sciammetta N; Scolastico C
Bioorg Med Chem; 1998 Nov; 6(11):2013-27. PubMed ID: 9881093
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the chemical development of angiotensin II receptor antagonists.
Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
14. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
15. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyrimidine angiotensin II receptor antagonists.
Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
19. Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; Rodríguez R; Carceller E; García-Rafanell J; Forn J
J Med Chem; 1996 May; 39(11):2197-206. PubMed ID: 8667363
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and angiotensin II receptor antagonist activity of C-linked pyrazole derivatives.
Nicolaï E; Curé G; Goyard J; Kirchner M; Teulon JM; Versigny A; Cazes M; Virone-Oddos A; Caussade F; Cloarec A
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1617-30. PubMed ID: 7954914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
